Can acotinib cure it?

Acalabrutinib is a BTK inhibitor used to treat B cell lymphoma, specifically in adults with chronic lymphocytic leukemia (CLL). Although acotinib has shown significant efficacy in controlling lymphoma growth and improving patient survival, few current cancer treatments are capable of complete cure. Acotinib is mainly used to relieve symptoms, delay disease progression, and improve patients' quality of life. Development of a treatment plan often requires individualized consideration and shared decision-making with a physician to maximize symptom relief and improve patient survival.